Evidence map›Paper›PMID 19264843›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2009

cAMP enhances estrogen-related receptor alpha (ERRalpha) transcriptional activity at the SP-A promoter by increasing its interaction with protein kinase A and steroid receptor coactivator 2 (SRC-2).

Dongyuan Liu, Houda Benlhabib, Carole R Mendelson

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Role of NRF2 in immune modulator expression in developing lung.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Regulation of the expression of the estrogen related receptors (ERRs).Cellular and molecular life sciences : CMLS · 2020
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Fetal-to-maternal signaling in the timing of birth.The Journal of steroid biochemistry and molecular biology · 2017
    Review
  16. Steroid receptor coactivators as therapeutic targets in the female reproductive system.The Journal of steroid biochemistry and molecular biology · 2015
    Review
  17. Article
  18. Fetal-to-maternal signaling to initiate parturition.The Journal of clinical investigation · 2015
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dongyuan LiuDepartment of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, 75390-9038, USA.
Houda Benlhabib
Carole R Mendelson
March of Dimes · USThe University of Texas Southwestern Medical Center · US

Funding

MECHANISMS IN THE REGULATION OF SP-A GENE EXPRESSIONR37HL050022 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI MENDELSON, CAROLE R. · 1998 to 2007
$3.2M
NHLBI NIH HHS R37 HL050022
6 · The paper itself

Abstract

Estrogen-related receptor (ERRalpha) plays a critical role in basal and cAMP-induced expression of the human surfactant protein-A (SP-A) gene in lung type II cells through direct binding to an ERR response element (ERRE, 5'-TGACCTTA-3') within its 5'-flanking region. Furthermore, protein kinase A (PKA) up-regulates ERRalpha activation of the hSP-A promoter. In the present study, using cultured human fetal lung type II cells, we observed that cAMP enhanced ERRalpha phosphorylation and nuclear expression levels. cAMP/PKA stimulation of ERRalpha activation of the SP-A promoter was blocked by the PKA inhibitor, H89, whereas the MAPK P38 inhibitor, SB203580, and the MAPK kinase inhibitor, PD98059, had negligible to modest effects. This suggests that cAMP acts selectively through PKA to increase ERRalpha transcriptional activity. Of several coactivators tested, steroid receptor coactivator 2 (SRC-2) had the most pronounced effect to increase ERRalpha transcriptional activity at the SP-A promoter; this was enhanced by cotransfection with PKA catalytic subunit (PKAcat). Interestingly, SRC-2, ERRalpha, and PKAcat in type II cell nuclear extracts interacted at the ERRE; this was enhanced by cAMP and inhibited by H89. cAMP increased in vivo binding of PKAcat and SRC-2 to the ERRE genomic region in lung type II cells. In mutagenesis studies, three serines (S87, S114, and S277) were found to be critical for PKA and SRC-2 induction of ERRalpha transcriptional activity. Collectively, these findings indicate that cAMP/PKA signaling enhances ERRalpha phosphorylation and nuclear localization, recruitment to the SP-A promoter, and interaction with PKAcat and SRC-2, resulting in the up-regulation of SP-A gene transcription.

Indexed as

AnimalsCell NucleusCyclic AMPCyclic AMP-Dependent Protein KinasesEnzyme ActivationERRalpha Estrogen-Related ReceptorFetusGenome, HumanHumansIsoquinolinesLungMiceNuclear Receptor Coactivator 2PhosphorylationPromoter Regions, GeneticProtein BindingCyclic AMPCyclic AMP-Dependent Protein KinasesERRalpha Estrogen-Related ReceptorIsoquinolinesN-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamideNuclear Receptor Coactivator 2Pulmonary Surfactant-Associated Protein AReceptors, EstrogenSerineSulfonamidesThreonine

Identifiers

PMID19264843
PMCPMC2691680
OpenAlexW2023579811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.